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CASE REPORT
Adult-onset bilateral
Parry-Romberg syndrome
Elizabeth Tkachenko, BS,a Michael J. Cunningham, MD,b Patrick J. O’Donnell, DO,c and
Nikki A. Levin, MD, PhDb
Worcester, Massachusetts
Key words: en coup de sabre; lipodystrophy; morphea.
INTRODUCTION
Parry-Romberg Syndrome (PRS), or progressive
hemifacial atrophy, is an uncommon disorder
characterized by progressive unilateral loss of adi-
pose tissue and underlying structures including
muscle, cartilage, and bone, often with little or no
sclerosis. PRS and morphea en coup de sabre
(ECDS) have significant overlap, often coexist,
and are likely different phenotypes of morphea.1
PRS usually presents in the first decade of life, but
later presentations have been described.1 It is more
common in females and the pathogenesis is not
completely understood.1 Neurologic symptoms are
the most common extracutaneous systemic mani-
festation. Bilateral disease occurs in rare instances.1
We describe a woman with profound bilateral facial
atrophy whose presentation does not follow the
typically reported disease course or histopathologic
findings seen in PRS.
REPORT OF A CASE
A 59-year-old Haitian woman who had moved to
the United States 1 year before presentation was
evaluated for bilateral facial atrophy. Approximately
20 years before presentation, she noted an itchy
patch on the left cheek and subsequently had pro-
found atrophy in this area. There was no history of
trauma or injections to the affected area nor of
preceding illness. Gradually over the last 2 decades,
she experienced progressive bilateral facial atrophy
(Fig 1). The affected areas were otherwise asymp-
tomatic, and she continued to have full facial range
ofmotion. In the 2 years before presentation, she had
significant headaches and dizziness. On clinical
examination, she had profound retroorbital and
periorbital fat loss giving a sunken eye appearance
and profound preauricular fat pad loss with cadav-
eric facies. Additionally, she had bilateral linear
depressions with hyperpigmentation on the para-
median forehead and complete alopecia of bilateral
eyebrows and frontal scalp. Scleroderma-like
changes were not observed. The tongue, teeth, and
gums were spared.
Medical history was notable only for hyperten-
sion, treated with chlorthalidone. Family history was
negative for morphea or lipodystrophy. HIV testing
was negative. Antinuclear antibodies, Scl-70 and
SSA/SSB antibodies were negative. Urinalysis, C3
(171 mg/dL), and CH50 ([60 U/mL) were within
normal limits. A punch biopsy of the left lesional
cheek, down to visible fascia, found complete loss of
peri-eccrine adipose tissue with mild chronic peri-
folliculitis and perivascular lymphocytic infiltrate.
Findings consistent with morphea were not
observed, and the remaining adipose tissue was
unremarkable (Fig 1). Lupus band test and Alcian
blue stain for stromal mucin were both negative.
Magnetic resonance imaging (MRI) and computed
tomography scan showed marked thinning of the
skin and subcutaneous fat loss of the face with
bilateral enophthalmos. Cerebral MRI found scat-
tered T2 hyperintensities and chronic ischemic
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changes, both of which were stable over 1 year in
consecutive MRIs.
DISCUSSION
The clinical presentation of adult-onset bilateral
facial atrophy suggests bilateral PRS. This syndrome
classically presents in adolescence as a progressive
unilateral loss of adipose tissue and underlying
structures (muscle, cartilage, and bone) often with
little or no sclerosis. Although most symptoms
develop during the first decade of life, onset as late
as 75 years of age has been reported.1 Females are 2
to 3 times more likely to be affected than males.1,2
Bilateral disease is a relatively rare occurrence,
observed in 2% to 7% of cases.1,2 Seizures and
headaches are the most common neurologic mani-
festations of PRS, reported in 10% to 40% and 20% of
patients, respectively.1,3 Neuroimaging in PRS
frequently finds bilateral abnormalities that are high-
ly variable, inconsistently associated with neurologic
symptoms, and often do not correlate with cuta-
neous activity.4 Pathogenesis of these neurological
findings in PRS is largely speculative and likely
multifactorial.4 Proposed mechanisms include in-
flammatory and autoimmune etiologies.4 Because
T2 hyperintensity on MRI is one of the imaging
findings reported in PRS, neurologist review of our
case proposed that her MRI findings could be due to
PRS, although age-related changes cannot be
excluded given that the patient is older than the
typical PRS cohort.
The differential diagnosis of PRS includes
Barraquer-Simons syndrome (Table I). The diagnosis
of atypical Barraquer-Simons syndrome was strongly
Fig 1. Symmetrical subcutaneous fat loss of the cheeks, temples, forehead, and periorbital skin
in a 59-year-old HIV-negative woman (A and B) with complete loss of peri-eccrine adipose
tissue on punch biopsy of the left lesional cheek (C and D).
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Table I. Acquired lipoatrophy syndromes4,8,9
Age of onset Sex (F:M) Body areas affected Clinical features Histopathologic features Associated diseases
Acquired partial
lipodystrophy
(Barraquer-
Simons
syndrome)
Childhood or
adolescence,
rarely adult
3:1 Decreased fat face,
upper
extremities, and
trunk with
cephalocaudal
spread
Increased fat hips,
legs
- Loss retroorbital and perior-
bital tissue
- Loss preauricular fat pads
- Hips and legs spared,
often demonstrating fat
hypertrophy
Two patterns:
1. Noninflammatory with invo-
lutional changes of fat
(reduction size and number
adipocytes)
2. Inflammatory lobular panni-
culitis with lymphocytes, lip-
ophages, plasma cells
- Diabetes mellitus
- Elevated triglycerides
- Mesangiocapillary
glomerulonephritis
- Autoimmune disease: SLE,
dermatomyositis
- Circulating C3 nephritic factor
Parry-Romberg
syndrome
(progressive
hemifacial
atrophy)
Adolescence,
average
13.6 years old
3:1 Forehead, nose,
medial cheek,
upper lip (total
hemifacial
involvement)
- Paramedian atrophy
- No overlying skin induration
- Atrophy may extend down
entire face
- Fat atrophy
- Decrease in adnexal
structures
- Mononuclear cell infiltrate
- Atrophy and deformity
tongue, teeth, gingiva
- Neurologic abnormalities
- Ophthalmologic
abnormalities
Morphea ECDS Adolescence,
average 10 years
old
2:1 e 3:1 Frontoparietal and
scalp without
extension below
eyebrow
- Cutaneous induration and
sclerosis
- Scalp to forehead
- Hyperpigmentation
- Alopecia involving scalp/
eyebrow
- Dermal sclerosis
- Adnexal atrophy
- Mononuclear cell infiltrates
- Neurologic abnormalities
- Ophthalmologic
abnormalities
SLE, Systemic lupus erythematosus.
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considered because of the lack of morphea-like
changes on pathology, bilateral symmetrical facial
involvement, and no bone destruction. The two
diseases may be associated, with some references
classifying bilateral progressive facial atrophy as
Barraquer-Simons syndrome.5,6
PRS is mostly a clinical diagnosis often supported
by histopathology and imaging. The biopsies from
our patient exhibited lipoatrophy without morphea
changes. Although most cases of ECDS exhibit
morphea findings (fibrosis and adnexal atrophy)
on skin biopsy, these findings are found in aminority
of PRS patients.7 It is possible that the patient has
both PRS and ECDS, and if biopsies were taken from
the forehead rather than the cheeks, changes of
morphea would have been seen. ECDS and PRS
share significant overlap. Although facial distribution
of morphea-like changes may differentiate these
entities, with ECDS characteristically above the
eyebrows and PRS below, more than 50% of PRS
patients were found to have concomitant ECDS.1
Additionally, neurological symptoms are reported in
both conditions.1
The natural history of PRS is slow progression
over several years followed by a plateau. The goal of
therapy is to prevent disease progression. Activity of
the disease in our patient was questionable, as there
were no recent photographs. Because of the unex-
plained headaches and unclear rate of disease pro-
gression, the patient was started on methotrexate,
25 mg/week. She is treated by the neurology
department for headaches and the ophthalmology
department for enophthalmos and was referred to a
plastic surgeon for a fat grafting procedure. This case
is an unusual presentation of bilateral facial atrophy
in an adult female most consistent with bilateral PRS.
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